Genmab A/S (GMAB.CO)
Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
As of 04:27PM CEST. Market open.
| Previous close | 2,061.00 |
| Open | 2,050.00 |
| Bid | 2,015.00 x N/A |
| Ask | 2,017.00 x N/A |
| Day's range | 2,002.00 - 2,056.00 |
| 52-week range | 1,825.00 - 2,939.00 |
| Volume | |
| Avg. volume | 127,897 |
| Market cap | 130.354B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 24.27 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to […]
- GuruFocus.com
Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
Explore key insights from Comstock Inc's Q1 2024 earnings, including significant revenue streams, strategic investments, and future financial strategies.
- Investor's Business Daily
Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
© 2024 Yahoo. All rights reserved.